Royal Pharmaceutical Society 3 July 2018
- The Royal Pharmaceutical Society have developed guidance to outline the size of the challenge of problematic polypharmacy, highlight the good work being done to address it and make clear recommendations to organisations and individuals involved with medicines as part of the care of the people they serve.
- The guidance is out for consultation until 28 August 2018.
